01 6Amgen Canada Inc.
01 22045869
02 12123593
03 22366785
04 12476934
01 6Etanercept
01 3Lyophilized Powder for Reconstitution
02 3Solution
01 22011-06-27
02 12013-09-14
03 22020-04-19
04 12023-02-27
Patent Expiration Date : 2020-04-19
Date Granted : 2012-02-07
Brand Name : ENBREL
Patent Number : 2366785
Filing Date : 2000-04-19
Strength per Unit : 25 mg / vial
Dosage Form : Lyophilized Powder for Reconstitution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2020-04-19
Date Granted : 2012-02-07
Patent Expiration Date : 2020-04-19
Date Granted : 2012-02-07
Brand Name : ENBREL
Patent Number : 2366785
Filing Date : 2000-04-19
Strength per Unit : 50 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2020-04-19
Date Granted : 2012-02-07
Patent Expiration Date : 2013-09-14
Date Granted : 2000-03-14
Brand Name : ENBREL
Patent Number : 2123593
Filing Date : 1993-09-14
Strength per Unit : 25 mg / vial
Dosage Form : Lyophilized Powder for Reconstitution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2013-09-14
Date Granted : 2000-03-14
Patent Expiration Date : 2011-06-27
Date Granted : 2009-01-27
Brand Name : ENBREL
Patent Number : 2045869
Filing Date : 1991-06-27
Strength per Unit : 25 mg / vial
Dosage Form : Lyophilized Powder for Reconstitution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2011-06-27
Date Granted : 2009-01-27
Patent Expiration Date : 2023-02-27
Date Granted : 2009-06-16
Brand Name : ENBREL
Patent Number : 2476934
Filing Date : 2003-02-27
Strength per Unit : 50 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2023-02-27
Date Granted : 2009-06-16
Patent Expiration Date : 2011-06-27
Date Granted : 2009-01-27
Brand Name : ENBREL
Patent Number : 2045869
Filing Date : 1991-06-27
Strength per Unit : 50 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2011-06-27
Date Granted : 2009-01-27
